Inventor · disambiguated record
Stephen E. Webber
Also filed as: WEBBER STEPHEN E · WEBBER STEPHEN EVAN
58 granted patents·22 pending applications·1,123 citations·filing 1984–2024
99Inventor score
Files withAGOURON PHARMA18ANADYS PHARMACEUTICALS INC16EFFECTOR THERAPEUTICS INC13PRIMMUNE THERAPEUTICS INC6WEBBER STEPHEN E5
Top patents by PatentIndex Score
80 records- 0198US5955509ApH dependent polymer micellesUNIV TEXAS·Filed 1997·Granted Sep 21, 1999·263 cites·10 claims
- 0297US6924271B23-β-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2002·Granted Aug 2, 2005·123 cites·10 claims
- 0395US9382248B2Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2015·Granted Jul 5, 2016·14 cites·25 claims
- 0495US7705007B2Cis-imidazolinesHOFFMANN LA ROCHE·Filed 2007·Granted Apr 27, 2010·26 cites·11 claims
- 0595US6495541B1Tricyclic inhibitors of poly(ADP-ribose) polymerasesAGOURON PHARMA·Filed 2000·Granted Dec 17, 2002·76 cites·5 claims
- 0694US9669031B2MNK inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2016·Granted Jun 6, 2017·12 cites·20 claims
- 0794US4759880AAlkanoarachidonic acidsRESEARCH CORP·Filed 1984·Granted Jul 26, 1988·43 cites·19 claims
- 0892US7964724B2Chiral cis-imidazolinesHOFFMANN LA ROCHE·Filed 2005·Granted Jun 21, 2011·21 cites·10 claims
- 0992US7560544B23,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereofANADYS PHARMACEUTICALS INC·Filed 2005·Granted Jul 14, 2009·16 cites·12 claims
- 1091US7579368B2Cis-imidazolinesHOFFMANN LA ROCHE·Filed 2006·Granted Aug 25, 2009·11 cites·42 claims
- 1191US7429578B2Tricyclic inhibitors of poly(ADP-ribose) polymerasesAGOURON PHARMA·Filed 2005·Granted Sep 30, 2008·16 cites·5 claims
- 1290US7425638B2Cis-imidazolinesHOFFMANN LA ROCHE·Filed 2004·Granted Sep 16, 2008·31 cites·5 claims
- 1390US6548494B1Tricyclic inhibitors of poly(ADP-ribose) polymerasesAGOURON PHARMA·Filed 2000·Granted Apr 15, 2003·48 cites·13 claims
- 1490US5430148AAntiproliferative quinazolinesAGOURON PHARMA·Filed 1992·Granted Jul 4, 1995·75 cites·42 claims
- 1589US9814718B2MNK inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2017·Granted Nov 14, 2017·5 cites·20 claims
- 1689US8097718B23,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereofWEBBER STEPHEN E·Filed 2009·Granted Jan 17, 2012·11 cites·31 claims
- 1789US7709448B2Prodrugs of 5-amino-3-(3′-deoxy-β-D-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dioneANADYS PHARMACEUTICALS INC·Filed 2007·Granted May 4, 2010·13 cites·8 claims
- 1886US9822122B2Indoline analogs and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2017·Granted Nov 21, 2017·4 cites·10 claims
- 1986US6362166B1Antipicornaviral compounds and methods for their use and preparationAGOURON PHARMA·Filed 2000·Granted Mar 26, 2002·14 cites·45 claims
- 2085US11130757B2Crystalline forms of MNK inhibitorsEFFECTOR THERAPEUTICS INC·Filed 2019·Granted Sep 28, 2021·2 cites·10 claims
- 2185US10000487B2Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancersEFFECTOR THERAPEUTICS INC·Filed 2016·Granted Jun 19, 2018·5 cites·5 claims
- 2285US7745415B23-β-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2008·Granted Jun 29, 2010·6 cites·12 claims
- 2385US7582754B2Pyrro[1,2-b]pyridazinone compoundsANADYS PHARMACEUTICALS INC·Filed 2008·Granted Sep 1, 2009·6 cites·4 claims
- 2484US6977298B2Tricyclic inhibitors of poly(ADP-ribose) polymerasesCANCER RES CAMPAIGN TECH·Filed 2004·Granted Dec 20, 2005·16 cites·8 claims
- 2583US7462611B2Pyrro[1,2-b]pyridazinone compoundsANADYS PHARMACEUTICALS INC·Filed 2007·Granted Dec 9, 2008·5 cites·23 claims
- 2683US7425552B2Pyridazinone compoundsANADYS PHARMACEUTICALS INC·Filed 2005·Granted Sep 16, 2008·7 cites·14 claims
- 2782US10711008B2Indoline analogs and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2019·Granted Jul 14, 2020·1 cites·6 claims
- 2881US10351569B2Indoline analogs and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2017·Granted Jul 16, 2019·2 cites·13 claims
- 2981US5962487AAntipicornaviral compounds and methods for their use and preparationAGOURON PHARMA·Filed 1997·Granted Oct 5, 1999·25 cites·34 claims
- 3081US5707992AAntiproliferative quinazolinesAGOURON PHARMA·Filed 1995·Granted Jan 13, 1998·44 cites·60 claims
- 3180US10112955B2Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2EFFECTOR THERAPEUTICS INC·Filed 2016·Granted Oct 30, 2018·2 cites·19 claims
- 3280US6534530B1Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesisAGOURON PHARMA·Filed 2000·Granted Mar 18, 2003·12 cites·28 claims
- 3379US7943759B23-β-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2010·Granted May 17, 2011·3 cites·6 claims
- 3478US2025129077A1Substituted purines as tlr7 agonistsPRIMMUNE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3577US12187759B2TLR7 agonistsPRIMMUNE THERAPEUTICS INC·Filed 2023·Granted Jan 7, 2025·0 cites·14 claims
- 3677US5856530AAntipicornaviral compounds and methods for their use and preparationAGOURON PHARMA·Filed 1997·Granted Jan 5, 1999·32 cites·29 claims
- 3777US5272240AFast sol-gel preparation of glassesUNIV TEXAS·Filed 1991·Granted Dec 21, 1993·36 cites·37 claims
- 3876US8883758B23,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereofWEBBER STEPHEN E·Filed 2013·Granted Nov 11, 2014·2 cites·12 claims
- 3976US7321033B23-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2004·Granted Jan 22, 2008·7 cites·11 claims
- 4076US5885996AAntiproliferative quinazolinesAGOURON PHARMA·Filed 1997·Granted Mar 23, 1999·36 cites·6 claims
- 4175US7528115B2Carbonate and carbamate prodrugs of thiazolo[4,5-d]pyrimidinesANADYS PHARMACEUTICALS INC·Filed 2007·Granted May 5, 2009·2 cites·15 claims
- 4275US2021338673A1Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4372US8097613B2[1,2,4]thiadiazine 1,1-dioxide compoundsRUEBSAM FRANK·Filed 2009·Granted Jan 17, 2012·2 cites·28 claims
- 4470US11952375B2Crystalline forms of Mnk inhibitorsEFFECTOR THERAPEUTICS INC·Filed 2021·Granted Apr 9, 2024·0 cites·6 claims
- 4570US11059824B2Substituted purines as TLR7 agonistsPRIMMUNE THERAPEUTICS INC·Filed 2019·Granted Jul 13, 2021·0 cites·4 claims
- 4670US6953858B2HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesisAGOURON PHARMA·Filed 2002·Granted Oct 11, 2005·4 cites·16 claims
- 4768US12037335B2Substituted purines as TLR7 agonistsPRIMMUNE THERAPEUTICS INC·Filed 2021·Granted Jul 16, 2024·0 cites·14 claims
- 4868US7842838B2Pyrro[1,2-b]pyridazinone intermediatesANADYS PHARMACEUTICALS INC·Filed 2009·Granted Nov 30, 2010·0 cites·4 claims
- 4966US6995142B2Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesisAGOURON PHARMA·Filed 2002·Granted Feb 7, 2006·2 cites·52 claims
- 5066US2019209560A1Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 80 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →